accountto capture that market. It���s high quality and delivering an excellent growth story.��� Both Pfizer Inc. and GlaxoSmithKline Plc may be potential buyers of Shire given that both are expanding into rare diseases, Malik said. Teva Pharmaceutical...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Shires Sore Thumb Growth May... 12:27 PM
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account